![Larn Hwang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Larn Hwang
Directeur Technique/Scientifique/R&D chez
Oncotelic, Inc.
Fortune : 1 M $ au 30/06/2026
Profil
Larn Hwang founded Biomiga Diagnostics Co. in 2011, where she worked as Chief Operating Officer from 2011 to 2013 and IgDraSol, Inc. in 2012, where she worked as VP-Regulatory & Clinical Operations from 2012 to 2014.
Dr. Hwang also currently works at Autotelic, Inc., as Chief Scientific Officer from 2013 and Oncotelic, Inc., as Chief Scientific Officer.
Dr. Hwang also formerly worked at Abraxis BioScience, Inc., as Head-Cell Biology from 2005 to 2011 and Adhera Therapeutics, Inc., as Chief Scientific Officer.
Dr. Hwang received her doctorate degree from The University of Texas Southwestern Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases 5,28% | 12/04/2025 | 23 455 990 ( 5,28% ) | 1 M $ | 30/06/2026 |
Postes actifs de Larn Hwang
| Sociétés | Poste | Début |
|---|---|---|
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Directeur Technique/Scientifique/R&D | - |
Autotelic, Inc.
 Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics drugs | Directeur Technique/Scientifique/R&D | 01/10/2013 |
Anciens postes connus de Larn Hwang
| Sociétés | Poste | Fin |
|---|---|---|
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer therapeutics | Fondateur | 01/05/2014 |
Biomiga Diagnostics Co. | Fondateur | 01/08/2013 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Corporate Officer/Principal | 01/06/2011 |
| ADHERA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Larn Hwang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Biomiga Diagnostics Co. | |
IgDraSol, Inc.
IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer therapeutics | Health Technology |
Autotelic, Inc.
Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics drugs | Health Technology |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Develops RNA therapeutics and small molecule drugs targeting cancer and infectious diseases | Health Technology |
